BULIS VERONICA SANCHEZ (VP, Corporate Controller) sold 4.0% of their position (621.00 shares) of LYELL IMMUNOPHARMA, INC. on the open market
Open‑market sale worth $8.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/11/2026ACC: 0002095702-26-000005
Officer· VP, Corporate Controller
Since Feb 2026
-621.00
Net shares
Net seller
$8.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
621.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−621.00
Price / share
$14.34
Trade value
$8.91K
% of position
4.0%
8/10/2026
15.42K→14.80K
Total
Net shares
−621.00
Net value
-$8.91K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/10/2026 | S · Sale | −621.00 | $14.34 | $8.91K | 4.0% | 15.42K | 14.80K |
| Total | −621.00 | -$8.91K | ||||||
Derivative Transactions0
No derivative transactions reported